Trial Profile
A retrospective trial comparing length of stay after prophylactic treatment of oral valganciclovir and preemptive treatment of ganciclovir in high-risk (D+/R-) cytomegalovirus patients who underwent solid organ transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2016
Price :
$35
*
At a glance
- Drugs Valganciclovir (Primary) ; Ganciclovir
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- 09 Jun 2016 New trial record
- 25 May 2016 Results presented at the 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research